Look for:

Our offer for

AB SCIENCE S.A.


ISIN:
FR0010557264
WKN:
-

2022/07/07 08:05:28
Price
7.91 EUR
Difference 1.35% (0.11)

General attributes

ISINFR0010557264
SymbolAB
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)369 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)7.695 EUR (404)
Ask (Ask size)7.81 EUR (398)
Open7.91 EUR
High7.91 EUR
Low7.91 EUR
Close (prev. day)7.805 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Annual report: AB SCIENCE S.A.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/07/07 08:05:28
Price
7.91 EUR
Difference 1.35% (0.11)

General attributes

ISINFR0010557264
SymbolAB
ExchangeBerlin
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)369 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)7.695 EUR (404)
Ask (Ask size)7.81 EUR (398)
Open7.91 EUR
High7.91 EUR
Low7.91 EUR
Close (prev. day)7.805 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades1
Last size0

Performance and Risk

6M1Y3Y
Perf (%)-35.76%-20.68%+74.22%
Perf (abs.)-4.35-2.04+3.33
Beta1.230.920.63
Volatility77.5873.8275.77
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)7.99 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)9.32 EUR (0)
Ø price 100 days | Ø volume 100 days (pcs.)9.46 EUR (0)
Ø price 250 days | Ø volume 250 days (pcs.)11.23 EUR (0)
YTD High | date12.61 EUR (2022/01/04)
YTD Low | date7.39 EUR (2022/02/22)
52 Weeks High | date15.71 EUR (2021/07/21)
52 Weeks Low | date7.39 EUR (2022/02/22)

All listings for AB SCIENCE S.A.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2022/07/0711:467.77 EUR0.002
Stuttgart2022/07/0713:067.725 EUR0.005
Munich2022/07/0708:057.91 EUR0.001
London Stock Exchange2022/05/1615:459.475 EUR0.001
Frankfurt2022/07/0708:077.905 EUR0.001
FINRA other OTC Issues2022/06/0320:5910.60 USD0.001
Euronext Paris2022/07/0713:007.765 EUR0.14121
Duesseldorf2022/07/0713:007.725 EUR0.008
Berlin2022/07/0708:057.91 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=137388&ID_TYPE_IMAGE_LOGO=2

Contact Details

AB SCIENCE SA
- -
3, avenue George V - 75008 Paris
Telefon: 33-1-47-20-00-14
Fax: 33-1-47-20-24-11
E-mail: contact@ab-science.com

PDF Downloads

Annual report: AB SCIENCE S.A.PDF Download

Company Profile

AB Science SA operates as a pharmaceutical company. The firm specializes in the research, development and commercialization of protein kinase inhibitors (PKIs), a class of targeted proteins whose action are key in signaling pathways within cells. Its pipeline includes Masitinib and AB8939. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.


Board of directors

Catherine Johnston-RoussillonMember of Supervisory Board
Cécile de GuillebonMember of Supervisory Board
Guillemette LatschaMember of Supervisory Board
Patrick MoussyMember of Supervisory Board
Renaud SassiMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.